The U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less dangerous, in one of the biggest ch…
The United States Department of Justice is easing rules on certain marijuana items. The drug will be reclassified as less dangerous. This significant policy shift impacts the multi-billion dollar cannabis industry. It aims to reduce
The Trump administration reclassified medical marijuana as a less
read morePresident Donald Trump’s acting attorney general on Thursday signed
read moreRescheduling could reshape cannabis industry dynamics, impacting market perceptions,
read moreThe Department of Justice said it will immediately move
read moreThe US Department of Justice has reclassified medical cannabis
read morePresident Donald Trump’s administration has reclassified medical marijuana as
read moreActing Attorney General Todd Blanche’s distinction between medical and
read moreCHICAGO Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE:
read moreResearchers at the University of Arizona Health Sciences say they have identified a THC-free cannabis compound that may help treat some forms of pain. The work is positioned as a
read moreThe US Justice Department reclassified state-regulated marijuana as a less dangerous drug, a major shift that could increase legal cannabis sales and help a struggling industry. The directive signed…
read moreWhen researchers at NYU Langone Health examined cancerous prostate tissue under specialized laboratory equipment, they found something they weren’t looking for: microscopic fragments of plastic embed…
read morePresident Donald Trump is urging congressional lawmakers to take action to amend a law that threatens to federally recriminalize hemp-derived full-spectrum CBD products in November. “I am calling on…
read moreFor the first time since 1970, the federal government has reclassified marijuana from the most dangerous category downward into a less dangerous category. Dr. Jon LaPook breaks it down. Copyright
read moreThe cautious market response highlights uncertainty in cannabis reform, with potential legal hurdles impacting broader industry progress. The post DOJ finalizes cannabis rescheduling to Schedule III, market reacts with caution
read moreThe reclassification could pave the way for broader acceptance and regulatory changes, impacting medical research and market dynamics. The post
Be the first to receive the latest buzz contests & more!